Background In October 2017, our hospital saw the opening of a cardiology centre specialising in the treatment of cardiovascular diseases. With a capacity of 120 beds, the cost of health products that were granted for the launch of this structure was €2,199,374.16. The medication use process (MUP) is one of the most critical processes in any hospital practice, involving many stages and different care staff who require the transfer of information and products. As a result, to improve and secure the MUP, good communication between the pharmacy and the various departments of the centre is required. This initiative is the first of its kind in our institution.
Purpose To study the current state of communication between the pharmacy and the medical and surgical services of the cardiology centre, as well as the constraints encountered in the dispensing of health products, in order to improve their collaboration.
Material and methods This study took place between November 2017 and January 2018, at our institution’s cardiology centre, by means of a weekly monitoring sheet of pharmaceutical products composed of three parts:
General information on prescribing made in all centre services.
Constraints encountered and described at the end of the interview between the corresponding pharmacist and services manager.
Measures taken by the pharmacy department to respond to each constraint.
Results During this study, the deputy general manager cardiology, the deputy general manager interventional cardiology and heads of nursing were consulted, with a participation rate of 100%. The average length of interviews was 17 min. Among the constraints declared were, endowments deemed insufficient (66.07%) and unwanted drug substitutions (48;21%). The main causes of constraints reported were almost all communication problems between nurses and pharmacy technicians (91.07%). In counterpart, the main perfectible points identified by the corresponding pharmacist were: an under-declaration of adverse drug reactions as well as a slight irregularity concerning the traceability of pacemaker record sheets (lack in 8.10% of cases).
Conclusion Those pharmaceutical interventions made it possible to optimize the pharmacy department collaboration with the cardiology centre and to avoid globalised and nominative endowments delays.
References and/or acknowledgements Acknowledgements to the Congress.
No conflict of interest.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.